GlassScriptPhysician profile
Townsen G Kennington
NPI 1558981001
$19,585.28
in general payments reported to CMS, 2019-2025
23 companies · $5,624 in 2025
The $5,624 reported for 2025 was more than what 96% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,490 · 2023: $2,725 · 2024: $8,746 · 2025: $5,624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Food and Beverage: $6,316 · Entertainment: $15.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,764.10 |
| Food and Beverage | $6,315.96 |
| Entertainment | $15.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,181.38 | 2022-2025 | Ortholoc 3di, Augment Injectable, Hoffmann |
| Orthofix Medical, INC. | $3,070.94 | 2024 | Truelok |
| Paragon 28, INC. | $2,496.18 | 2023-2025 | Portfolio, Monkey Rings |
| Arthrex, INC. | $1,478.05 | 2025 | |
| Novus Surgical Solutions LLC | $1,421.77 | 2022 | |
| Vilex LLC | $1,241.63 | 2024 | |
| Medshape, INC. | $1,193.78 | 2024 | Dynanail |
| Novus Surgical Consultants | $848.14 | 2022-2025 | |
| Treace Medical Concepts, INC. | $509.43 | 2023 | |
| Horizon Therapeutics Plc | $489.36 | 2022-2023 | Krystexxa |
| Acumed LLC | $408.41 | 2023 | Acumed, Innate Implant |
| Smith+Nephew, INC. | $313.78 | 2023-2024 | Grafix Pl, Stravix Pl, Grafix |
| Kerecis Limited | $148.07 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Cerapedics INC. | $130.50 | 2022 | |
| Organogenesis INC. | $125.00 | 2023 | Affinity |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $124.74 | 2024 | Strensiq |
| Kci USA, INC. | $121.05 | 2022-2023 | Activ.A.C. Ion Progress, V.A.C. Veraflo Cleanse Choice |
| Integra Lifesciences Corporation | $117.08 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbvie INC. | $87.87 | 2022 | |
| Medical Device Business Services, INC. | $29.03 | 2024 | Fibulink |
| Urgo Medical North America, LLC | $20.83 | 2025 | Urgok2 |
| Musculoskeletal Transplant Foundation INC. | $15.40 | 2023 | |
| Depuy Synthes Sales INC. | $12.86 | 2023 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Townsen Kennington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.